Development of a novel preclinical pancreatic cancer research model: Bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts

Translational Oncology

Volumn 5, Issue 2, 2012, Pages 77-84

  Tuli, Richard ^a,b   Surmak, Andrew ^a   Reyes, Juvenal ^a   Hacker Prietz, Amy ^a   Armour, Michael ^a   Leubner, Ashley ^a   Blackford, Amanda ^a   Tryggestad, Erik ^a   Jaffee, Elizabeth M ^a   Wong, John ^a   DeWeese, Theodore L ^a   Herman, Joseph M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER INHIBITION; CANCER RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; FEMALE; IRRADIATION; MOUSE; NONHUMAN; PANCREAS CANCER; PHOTON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION DOSE; STAINING; TREATMENT RESPONSE; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84859463360     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11316     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, and Thun MJ (2009). Cancer statistics, 2009. CA Cancer J Clin 59, 225-249.
2. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, et al. (2008). Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26, 3503-3510.
3. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, et al. (2004). A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350, 1200-1210.
4. Strimpakos A, Saif MW, and Syrigos KN (2008). Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer Metastasis Rev 27, 495-522.
5. Stojadinovic S, Low DA, Hope AJ, Vicic M, Deasy JO, Cui J, Khullar D, Parikh PJ, Malinowski KT, Izaguirre EW, et al. (2007). MicroRT-small animal conformal irradiator. Med Phys 34, 4706-4716.
6. Zhou H, Rodriguez M, van den Haak F, Nelson G, Jogani R, Xu J, Zhu X, Xian Y, Tran PT, Felsher DW, et al. (2010). Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animals. Int J Radiat Oncol Biol Phys 78, 297-305.
7. Wong J, Armour E, Kazanzides P, Iordachita I, Tryggestad E, Deng H, Matinfar M, Kennedy C, Liu Z, Chan T, et al. (2008). High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys 71, 1591-1599.
8. Klerk CP, Overmeer RM, Niers TM, Versteeg HH, Richel DJ, Buckle T, Van Noorden CJ, and van Tellingen O (2007). Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43, 7-13, 30.
9. Lee CJ, Spalding AC, Ben-Josef E, Wang L, and Simeone DM (2010). In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation. Transl Oncol 3, 153-159.
10. Dalton WS (1999). The tumor microenvironment as a determinant of drug response and resistance. Drug Resist Updat 2, 285-288.
11. Bornmann C, Graeser R, Esser N, Ziroli V, Jantscheff P, Keck T, Unger C, Hopt UT, Adam U, Schaechtele C, et al. (2008). A new liposomal formulation of gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging. Cancer Chemother Pharmacol 61, 395-405.
12. Sun FX, Tohgo A, Bouvet M, Yagi S, Nassirpour R, Moossa AR, and Hoffman RM (2003). Efficacy of camptothecin analog DX-8951f (exatecan mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res 63, 80-85.
13. Sawtell NM (2002). Preparation of single cells from solid tissues for analysis by PCR. Curr Protoc Mol Biol Chapter 25, Unit 25A 22.
14. Voskoglou-Nomikos T, Pater JL, and Seymour L (2003). Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 9, 4227-4239.
15. Fidler IJ (2003). The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3, 453-458.
16. Nakamura T, Fidler IJ, and Coombes KR (2007). Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res 67, 139-148.
17. Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H, et al. (2006). An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12, 4652-4661.
18. Freytag SO, Paielli D, Wing M, Rogulski K, Brown S, Kolozsvary A, Seely J, Barton K, Dragovic A, and Kim JH (2002). Efficacy and toxicity of replicationcompetent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Int J Radiat Oncol Biol Phys 54, 873-885.
19. Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, Ballman KV, Kitange GJ, Guha A, Pandita A, et al. (2006). Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res 12, 2264-2271.
20. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH, Negrin RS, and Contag CH (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38, 2128-2136.
21. Wahl RL, Jacene H, Kasamon Y, and Lodge MA (2009). From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(suppl 1), 122S-150S.
22. Ford EC, Herman J, Yorke E, and Wahl RL (2009). 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med 50, 1655-1665.
23. Horn S, Barnard S, and Rothkamm K (2011). γ-H2AX-based dose estimation for whole and partial body radiation exposure. PLoS One 6, e25113.
24. Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, and Gupta N (2010). A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol 96, 151-159.